Our Portfolio

Recombinant Technologies, LLC

Pazhani Sundaram, PhD | CT, United States

Project Overview

  • Biotechnology/For Profit Organization Type
  • $0 Funding Amount
  • — 9/18/08 Project Duration
  • Drug Discovery Program
  • Status

Recombinant Technologies, LLC

Pazhani Sundaram, PhD | CT, United States

Preclinical safety testing of a drug for Alzheimer’s disease

GET IN TOUCH